374 related articles for article (PubMed ID: 16556274)
1. Basal cell carcinoma in Turkey.
Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
J Dermatol; 2006 Feb; 33(2):91-5. PubMed ID: 16556274
[TBL] [Abstract][Full Text] [Related]
2. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
3. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
4. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
5. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
Yap FB
Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma in Turkey.
Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
J Dermatol; 2005 Dec; 32(12):946-50. PubMed ID: 16471455
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
9. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
12. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
Gibson GE; Ahmed I
J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
[TBL] [Abstract][Full Text] [Related]
13. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous carcinoma of the skin: a case series.
Fu JM; McCalmont T; Yu SS
Arch Dermatol; 2009 Oct; 145(10):1152-8. PubMed ID: 19841403
[TBL] [Abstract][Full Text] [Related]
15. Active ascertainment of recurrence rate after treatment of primary basal cell carcinoma (BCC).
Alam M; Desai S; Nodzenski M; Dubina M; Kim N; Martini M; Fife D; Reid D; Pirigyi M; Poon E; Hsu J; Yoo S; Bhatia A
J Am Acad Dermatol; 2015 Aug; 73(2):323-5. PubMed ID: 26183979
[No Abstract] [Full Text] [Related]
16. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinomas: do they need to be followed up?
Park AJ; Strick M; Watson JD
J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
[TBL] [Abstract][Full Text] [Related]
18. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
20. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
